Cargando…
Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
Sequencing of cell-free DNA (cfDNA) is currently being used to detect cancer by searching both for mutational and non-mutational alterations. Recent work has shown that the length distribution of cfDNA fragments from a cancer patient can inform tumor load and type. Here, we propose non-negative matr...
Autores principales: | Renaud, Gabriel, Nørgaard, Maibritt, Lindberg, Johan, Grönberg, Henrik, De Laere, Bram, Jensen, Jørgen Bjerggaard, Borre, Michael, Andersen, Claus Lindbjerg, Sørensen, Karina Dalsgaard, Maretty, Lasse, Besenbacher, Søren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363120/ https://www.ncbi.nlm.nih.gov/pubmed/35894300 http://dx.doi.org/10.7554/eLife.71569 |
Ejemplares similares
-
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
por: Nørgaard, Maibritt, et al.
Publicado: (2017) -
Epigenetic silencing of MEIS2 in prostate cancer recurrence
por: Nørgaard, Maibritt, et al.
Publicado: (2019) -
Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
por: Bjerre, Marianne Trier, et al.
Publicado: (2020) -
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer
por: Hansen, Emma Bollmann, et al.
Publicado: (2022) -
Prostate Cancer Detection Rate of Manually Operated and Robot-assisted In-bore Magnetic Resonance Imaging Targeted Biopsy
por: Sandahl, Mads, et al.
Publicado: (2022)